Actuate is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutic agents for patients with cancer or inflammatory diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/17/19 | $21,700,000 | Series B |
Bios Partners DEFTA Partners Kairos Ventures  Tech Coast Angels | undisclosed |
| 11/12/19 | $6,500,000 | Series B-3 |
Bios Partners DEFTA Partners Kairos Ventures | undisclosed |
